KR101201852B1 - Fermented black garlic using vegetable lactic acid bacteria with yeast extract and mineral and a method thereof - Google Patents
Fermented black garlic using vegetable lactic acid bacteria with yeast extract and mineral and a method thereof Download PDFInfo
- Publication number
- KR101201852B1 KR101201852B1 KR1020100045574A KR20100045574A KR101201852B1 KR 101201852 B1 KR101201852 B1 KR 101201852B1 KR 1020100045574 A KR1020100045574 A KR 1020100045574A KR 20100045574 A KR20100045574 A KR 20100045574A KR 101201852 B1 KR101201852 B1 KR 101201852B1
- Authority
- KR
- South Korea
- Prior art keywords
- garlic
- black garlic
- lactic acid
- yeast extract
- acid bacteria
- Prior art date
Links
- 241000383638 Allium nigrum Species 0.000 title claims abstract description 96
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 title claims abstract description 66
- 241000894006 Bacteria Species 0.000 title claims abstract description 36
- 239000004310 lactic acid Substances 0.000 title claims abstract description 36
- 235000014655 lactic acid Nutrition 0.000 title claims abstract description 33
- 229940041514 candida albicans extract Drugs 0.000 title claims abstract description 25
- 239000012138 yeast extract Substances 0.000 title claims abstract description 25
- 229910052500 inorganic mineral Inorganic materials 0.000 title claims abstract description 23
- 239000011707 mineral Substances 0.000 title claims abstract description 23
- 235000013311 vegetables Nutrition 0.000 title claims abstract description 19
- 238000000034 method Methods 0.000 title claims description 20
- 240000002234 Allium sativum Species 0.000 claims abstract description 85
- 235000004611 garlic Nutrition 0.000 claims abstract description 84
- 230000032683 aging Effects 0.000 claims abstract description 10
- 238000004519 manufacturing process Methods 0.000 claims abstract description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 9
- 238000007710 freezing Methods 0.000 claims abstract description 4
- 230000008014 freezing Effects 0.000 claims abstract description 4
- 238000000227 grinding Methods 0.000 claims abstract description 4
- 230000003301 hydrolyzing effect Effects 0.000 claims abstract description 4
- 238000007789 sealing Methods 0.000 claims abstract description 4
- 230000001954 sterilising effect Effects 0.000 claims abstract description 4
- 238000001291 vacuum drying Methods 0.000 claims abstract description 4
- 238000010298 pulverizing process Methods 0.000 claims abstract description 3
- 238000000855 fermentation Methods 0.000 claims description 14
- 230000004151 fermentation Effects 0.000 claims description 14
- 239000011572 manganese Substances 0.000 claims description 6
- 239000011734 sodium Substances 0.000 claims description 6
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 claims description 4
- 239000011575 calcium Substances 0.000 claims description 4
- 239000000460 chlorine Substances 0.000 claims description 4
- 239000011651 chromium Substances 0.000 claims description 4
- 239000010949 copper Substances 0.000 claims description 4
- 229910052748 manganese Inorganic materials 0.000 claims description 4
- 239000011669 selenium Substances 0.000 claims description 4
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 claims description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 2
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims description 2
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 claims description 2
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims description 2
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 claims description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 2
- 241000186840 Lactobacillus fermentum Species 0.000 claims description 2
- ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 claims description 2
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 claims description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 2
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 claims description 2
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims description 2
- 229910052791 calcium Inorganic materials 0.000 claims description 2
- 229910052801 chlorine Inorganic materials 0.000 claims description 2
- 229910052804 chromium Inorganic materials 0.000 claims description 2
- 229910052802 copper Inorganic materials 0.000 claims description 2
- 239000011737 fluorine Substances 0.000 claims description 2
- 229910052731 fluorine Inorganic materials 0.000 claims description 2
- 229940029982 garlic powder Drugs 0.000 claims description 2
- 239000011630 iodine Substances 0.000 claims description 2
- 229910052740 iodine Inorganic materials 0.000 claims description 2
- 229940012969 lactobacillus fermentum Drugs 0.000 claims description 2
- 229910052750 molybdenum Inorganic materials 0.000 claims description 2
- 239000011733 molybdenum Substances 0.000 claims description 2
- 239000011574 phosphorus Substances 0.000 claims description 2
- 229910052698 phosphorus Inorganic materials 0.000 claims description 2
- 239000011591 potassium Substances 0.000 claims description 2
- 229910052700 potassium Inorganic materials 0.000 claims description 2
- 229910052711 selenium Inorganic materials 0.000 claims description 2
- 229910052708 sodium Inorganic materials 0.000 claims description 2
- 229910052717 sulfur Inorganic materials 0.000 claims description 2
- 239000011593 sulfur Substances 0.000 claims description 2
- JBQYATWDVHIOAR-UHFFFAOYSA-N tellanylidenegermanium Chemical compound [Te]=[Ge] JBQYATWDVHIOAR-UHFFFAOYSA-N 0.000 claims description 2
- 239000003963 antioxidant agent Substances 0.000 abstract description 6
- 230000036541 health Effects 0.000 abstract description 5
- 239000000126 substance Substances 0.000 abstract description 5
- 230000009286 beneficial effect Effects 0.000 abstract description 4
- 230000006872 improvement Effects 0.000 abstract description 3
- 239000000523 sample Substances 0.000 description 25
- 239000000243 solution Substances 0.000 description 19
- 238000002474 experimental method Methods 0.000 description 16
- 230000000694 effects Effects 0.000 description 14
- 239000000469 ethanolic extract Substances 0.000 description 14
- 238000002835 absorbance Methods 0.000 description 11
- 230000036039 immunity Effects 0.000 description 11
- 229930003935 flavonoid Natural products 0.000 description 10
- 235000017173 flavonoids Nutrition 0.000 description 10
- 238000005259 measurement Methods 0.000 description 10
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- 150000002215 flavonoids Chemical class 0.000 description 9
- 235000013305 food Nutrition 0.000 description 8
- 230000002401 inhibitory effect Effects 0.000 description 8
- 235000013824 polyphenols Nutrition 0.000 description 8
- 241000196324 Embryophyta Species 0.000 description 7
- 230000005764 inhibitory process Effects 0.000 description 7
- 239000000463 material Substances 0.000 description 7
- 150000008442 polyphenolic compounds Chemical class 0.000 description 7
- 230000005070 ripening Effects 0.000 description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- 108090000790 Enzymes Proteins 0.000 description 5
- 102000004190 Enzymes Human genes 0.000 description 5
- 235000006708 antioxidants Nutrition 0.000 description 5
- 238000010438 heat treatment Methods 0.000 description 5
- 230000001965 increasing effect Effects 0.000 description 5
- 210000004698 lymphocyte Anatomy 0.000 description 5
- 230000003266 anti-allergic effect Effects 0.000 description 4
- 230000003078 antioxidant effect Effects 0.000 description 4
- ABIUHPWEYMSGSR-UHFFFAOYSA-N bromocresol purple Chemical compound BrC1=C(O)C(C)=CC(C2(C3=CC=CC=C3S(=O)(=O)O2)C=2C=C(Br)C(O)=C(C)C=2)=C1 ABIUHPWEYMSGSR-UHFFFAOYSA-N 0.000 description 4
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 4
- 238000001727 in vivo Methods 0.000 description 4
- 150000002632 lipids Chemical class 0.000 description 4
- JDLKFOPOAOFWQN-VIFPVBQESA-N Allicin Natural products C=CCS[S@](=O)CC=C JDLKFOPOAOFWQN-VIFPVBQESA-N 0.000 description 3
- 239000006000 Garlic extract Substances 0.000 description 3
- 206010028980 Neoplasm Diseases 0.000 description 3
- JDLKFOPOAOFWQN-UHFFFAOYSA-N allicin Chemical compound C=CCSS(=O)CC=C JDLKFOPOAOFWQN-UHFFFAOYSA-N 0.000 description 3
- 235000010081 allicin Nutrition 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 238000010790 dilution Methods 0.000 description 3
- 239000012895 dilution Substances 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 235000020706 garlic extract Nutrition 0.000 description 3
- 238000000338 in vitro Methods 0.000 description 3
- 238000011081 inoculation Methods 0.000 description 3
- 244000005700 microbiome Species 0.000 description 3
- -1 potassium ferricyanide Chemical compound 0.000 description 3
- 235000019654 spicy taste Nutrition 0.000 description 3
- 239000012085 test solution Substances 0.000 description 3
- 230000005909 tumor killing Effects 0.000 description 3
- 229920001817 Agar Polymers 0.000 description 2
- 102000000588 Interleukin-2 Human genes 0.000 description 2
- 108010002350 Interleukin-2 Proteins 0.000 description 2
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 2
- 241000186660 Lactobacillus Species 0.000 description 2
- 244000199866 Lactobacillus casei Species 0.000 description 2
- 240000006024 Lactobacillus plantarum Species 0.000 description 2
- 235000013965 Lactobacillus plantarum Nutrition 0.000 description 2
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 2
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- NAXKFVIRJICPAO-LHNWDKRHSA-N [(1R,3S,4R,6R,7R,9S,10S,12R,13S,15S,16R,18S,19S,21S,22S,24S,25S,27S,28R,30R,31R,33S,34S,36R,37R,39R,40S,42R,44R,46S,48S,50R,52S,54S,56S)-46,48,50,52,54,56-hexakis(hydroxymethyl)-2,8,14,20,26,32,38,43,45,47,49,51,53,55-tetradecaoxa-5,11,17,23,29,35,41-heptathiapentadecacyclo[37.3.2.23,7.29,13.215,19.221,25.227,31.233,37.04,6.010,12.016,18.022,24.028,30.034,36.040,42]hexapentacontan-44-yl]methanol Chemical compound OC[C@H]1O[C@H]2O[C@H]3[C@H](CO)O[C@H](O[C@H]4[C@H](CO)O[C@H](O[C@@H]5[C@@H](CO)O[C@H](O[C@H]6[C@H](CO)O[C@H](O[C@H]7[C@H](CO)O[C@@H](O[C@H]8[C@H](CO)O[C@@H](O[C@@H]1[C@@H]1S[C@@H]21)[C@@H]1S[C@H]81)[C@H]1S[C@@H]71)[C@H]1S[C@H]61)[C@H]1S[C@@H]51)[C@H]1S[C@@H]41)[C@H]1S[C@H]31 NAXKFVIRJICPAO-LHNWDKRHSA-N 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 239000008272 agar Substances 0.000 description 2
- 230000003712 anti-aging effect Effects 0.000 description 2
- 230000001093 anti-cancer Effects 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 238000011088 calibration curve Methods 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 229940074391 gallic acid Drugs 0.000 description 2
- 235000004515 gallic acid Nutrition 0.000 description 2
- 210000000987 immune system Anatomy 0.000 description 2
- 230000006698 induction Effects 0.000 description 2
- 229940039696 lactobacillus Drugs 0.000 description 2
- 229940072205 lactobacillus plantarum Drugs 0.000 description 2
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 2
- 235000020778 linoleic acid Nutrition 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 230000036542 oxidative stress Effects 0.000 description 2
- 238000005502 peroxidation Methods 0.000 description 2
- 239000002504 physiological saline solution Substances 0.000 description 2
- SCVFZCLFOSHCOH-UHFFFAOYSA-M potassium acetate Chemical compound [K+].CC([O-])=O SCVFZCLFOSHCOH-UHFFFAOYSA-M 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 235000019640 taste Nutrition 0.000 description 2
- 239000000052 vinegar Substances 0.000 description 2
- 235000021419 vinegar Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- BNGXYYYYKUGPPF-UHFFFAOYSA-M (3-methylphenyl)methyl-triphenylphosphanium;chloride Chemical compound [Cl-].CC1=CC=CC(C[P+](C=2C=CC=CC=2)(C=2C=CC=CC=2)C=2C=CC=CC=2)=C1 BNGXYYYYKUGPPF-UHFFFAOYSA-M 0.000 description 1
- 241000234282 Allium Species 0.000 description 1
- 102000015427 Angiotensins Human genes 0.000 description 1
- 108010064733 Angiotensins Proteins 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 206010013911 Dysgeusia Diseases 0.000 description 1
- 239000004278 EU approved seasoning Substances 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 229910021578 Iron(III) chloride Inorganic materials 0.000 description 1
- 239000004201 L-cysteine Substances 0.000 description 1
- 235000013878 L-cysteine Nutrition 0.000 description 1
- 240000001929 Lactobacillus brevis Species 0.000 description 1
- 235000013958 Lactobacillus casei Nutrition 0.000 description 1
- 241000192130 Leuconostoc mesenteroides Species 0.000 description 1
- 241000234435 Lilium Species 0.000 description 1
- 241000191998 Pediococcus acidilactici Species 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 1
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 1
- 244000057717 Streptococcus lactis Species 0.000 description 1
- 235000014897 Streptococcus lactis Nutrition 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- SOIFLUNRINLCBN-UHFFFAOYSA-N ammonium thiocyanate Chemical compound [NH4+].[S-]C#N SOIFLUNRINLCBN-UHFFFAOYSA-N 0.000 description 1
- 230000003178 anti-diabetic effect Effects 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- 239000012470 diluted sample Substances 0.000 description 1
- HHEAADYXPMHMCT-UHFFFAOYSA-N dpph Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1[N]N(C=1C=CC=CC=1)C1=CC=CC=C1 HHEAADYXPMHMCT-UHFFFAOYSA-N 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 229960002089 ferrous chloride Drugs 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 235000011194 food seasoning agent Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- NMCUIPGRVMDVDB-UHFFFAOYSA-L iron dichloride Chemical compound Cl[Fe]Cl NMCUIPGRVMDVDB-UHFFFAOYSA-L 0.000 description 1
- RBTARNINKXHZNM-UHFFFAOYSA-K iron trichloride Chemical compound Cl[Fe](Cl)Cl RBTARNINKXHZNM-UHFFFAOYSA-K 0.000 description 1
- SUBFIBLJQMMKBK-UHFFFAOYSA-K iron(3+);trithiocyanate Chemical compound [Fe+3].[S-]C#N.[S-]C#N.[S-]C#N SUBFIBLJQMMKBK-UHFFFAOYSA-K 0.000 description 1
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 1
- 229940017800 lactobacillus casei Drugs 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 208000025113 myeloid leukemia Diseases 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 239000001967 plate count agar Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 235000011056 potassium acetate Nutrition 0.000 description 1
- 238000011533 pre-incubation Methods 0.000 description 1
- 229960001285 quercetin Drugs 0.000 description 1
- 235000005875 quercetin Nutrition 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 230000003716 rejuvenation Effects 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 239000012064 sodium phosphate buffer Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 230000007103 stamina Effects 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 235000019605 sweet taste sensations Nutrition 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- YNJBWRMUSHSURL-UHFFFAOYSA-N trichloroacetic acid Chemical compound OC(=O)C(Cl)(Cl)Cl YNJBWRMUSHSURL-UHFFFAOYSA-N 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 239000001052 yellow pigment Substances 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
- A23L27/10—Natural spices, flavouring agents or condiments; Extracts thereof
- A23L27/105—Natural spices, flavouring agents or condiments; Extracts thereof obtained from liliaceae, e.g. onions, garlic
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/15—Inorganic Compounds
- A23V2250/156—Mineral combination
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/20—Natural extracts
- A23V2250/218—Yeast extracts
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2300/00—Processes
- A23V2300/10—Drying, dehydrating
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
Landscapes
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Medicines Containing Plant Substances (AREA)
- Preparation Of Fruits And Vegetables (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
본 발명은 식물성유산균을 이용한 효모추출물 및 미네랄을 함유하는 발효흑마늘에 관한 것으로써, 보다 상세하게는 (a) 마늘에서 마늘의 외피 및 마늘의 내피를 제거하는 단계; (b) 상기 마늘의 외피 및 마늘의 내피가 제거된 마늘을 파쇄하는 단계; (c) 상기 파쇄된 마늘의 수분이 65%~75%가 되도록 수분을 조절하는 단계; (d) 상기 수분이 조절된 마늘을 밀봉용기에 넣어 밀봉하는 단계; (e) 상기 밀봉된 마늘을 60℃~90℃의 건조기에서 숙성시키는 단계; (f) 상기 숙성된 마늘에 상기 숙성된 마늘의 중량 대비 2배~10배 가수하고, 분쇄하여 흑마늘액을 제조하는 단계; (g) 상기 흑마늘액을 80℃~90℃에서 고온살균하는 단계; (h) 상기 살균된 흑마늘액에 효모추출물 및 미네랄을 첨가하는 단계; (i) 상기 효모추출물 및 미네랄이 첨가된 흑마늘액에 식물성유산균을 접종한 후, 37℃~45℃에서 발효시키는 단계; (j) 상기 발효된 흑마늘액을 -68℃~-80℃에서 동결하여 진공건조하는 단계; (k) 상기 건조된 발효흑마늘을 파쇄하여 분말화하는 단계;를 포함하는 것을 특징으로 하는 식물성유산균을 이용한 효모추출물 및 미네랄을 함유하는 발효흑마늘의 제조방법에 관한 것이다.
본 발명을 통해 식물성유산균을 이용하여 발효흑마늘을 제조하는데 소요되는 시간을 단축하고, 나아가 다양한 건강에 유리한 항산화 등의 기능성 물질을 첨가된 발효흑마늘을 제조할 수 있으며, 마늘 생산농가에 수익 창출은 물론 수익성 향상에 크게 기여하므로 산업상 이용가능성이 매우 우수하다고 할 것이다.The present invention relates to a fermented black garlic containing yeast extract and minerals using vegetable lactic acid bacteria, and more specifically, (a) removing the outer skin of garlic and the inner skin of garlic from garlic; (b) crushing garlic in which the outer skin of garlic and the inner skin of garlic are removed; (c) adjusting the moisture so that the water of the crushed garlic becomes 65% to 75%; (d) sealing the moisture-controlled garlic in a sealed container; (e) aging the sealed garlic in a dryer at 60 ℃ ~ 90 ℃; (f) hydrolyzing 2 to 10 times the weight of the aged garlic to the aged garlic, and grinding to prepare black garlic solution; (g) sterilizing the black garlic solution at 80 ° C to 90 ° C; (h) adding yeast extract and mineral to the sterilized black garlic solution; (i) inoculating the vegetable lactic acid bacteria to the black garlic solution to which the yeast extract and the mineral are added, and then fermenting at 37 ° C. to 45 ° C .; (j) freezing the fermented black garlic solution at -68 ℃ ~ -80 ℃ vacuum drying; (k) pulverizing the dried fermented black garlic and relates to a method for producing a fermented black garlic containing yeast extract and mineral using a vegetable lactic acid bacteria, characterized in that it comprises a.
Through the present invention, it is possible to shorten the time required to prepare fermented black garlic using vegetable lactic acid bacteria, and further prepare fermented black garlic added with functional substances such as antioxidants, which are beneficial to various health, and make profits to garlic producing farms. As it greatly contributes to profitability improvement, the industrial availability is very good.
Description
본 발명은 발효흑마늘에 관한 것으로서, 상기 발효흑마늘은 식물성유산균을 이용하고, 효모추출물 및 미네랄을 함유하는 것을 특징으로 한다.The present invention relates to fermented black garlic, the fermented black garlic is characterized in that it contains a yeast extract and minerals using vegetable lactic acid bacteria.
마늘(Allium sativum L.)은 다년생 구근식물로 백합과 알리움속에 속하며, 5천년 이상 재배 되어온 대표적인 경작식물의 하나이다. 예로부터 마늘이 기생충, 창상, 종양, 궤양, 두통 등에 효과가 있다하여 사용되어져 왔으며, 일반적인 효능으로는 동맥경화, 고혈압, 뇌졸중, 원기회복, 신경안정, 스태미너 증진 등에 효과가 있다고 알려져 있다.
Garlic (Allium sativum L.) is a perennial bulbous plant, belonging to the genus Lilium and Allium, and is one of the representative cultivated plants that have been grown for more than 5,000 years. Garlic has been used since it is effective in parasites, wounds, tumors, ulcers, headaches, etc., and general efficacy is known to be effective in atherosclerosis, hypertension, stroke, rejuvenation, nerve stabilization and stamina enhancement.
이런 다양하고 우수한 효과에도 불구하고 마늘의 주성분인 알리인(alliin)이 조직이 파쇄 될 때 알리네이즈(alliinase)라는 효소에 의해 마늘 특유의 냄새 성분인 알리신(allicin)으로 분해되어 독한 냄새를 유발하여 식용을 기피하는 한 원인으로 꼽히고 있다.
Despite these various and excellent effects, when garlic's main ingredient, allin, is broken down into allicin, a distinctive odor component of garlic, by an enzyme called allinase when tissue is crushed, it causes a poisonous odor. It is one of the reasons for avoiding food.
또한 생마늘을 그대로 섭취하면 위와 간에 자극을 주어 오히려 건강에 해를 끼칠 수도 있다. 식품이 가지고 있는 특유의 풍미는 열, 빛, 공기, 압력 등의 영향으로 소실되거나 변형 될 수 있으며, 특히 향은 열에 의해서 제거되기도 한다.
In addition, eating raw garlic as it may irritate the stomach and liver, rather may harm your health. Food's distinctive flavor can be lost or transformed under the influence of heat, light, air, pressure, etc. In particular, fragrance can be removed by heat.
마늘의 경우 특유의 향 성분인 알리신 과 매운맛은 70℃이상의 온도에서 제거된다. 따라서 마늘과 관련하여 마늘을 찌고 굽는 방법 등의 여려 유형이 발달되어 왔다. 그러나 직접적인 가열은 마늘이 갖고 있는 비타민이나 각종 미네랄 및 각종 아미노산 등의 성분을 파괴시키는 문제점이 있다.
In the case of garlic, the distinctive flavors of allicin and spicy taste are removed at temperatures above 70 ℃. Therefore, several types of garlic have been developed, such as how to steam and roast garlic. However, direct heating has a problem of destroying the components of vitamins, various minerals, and various amino acids that garlic has.
따라서 간접적으로 열을 가하는 방식인 건조열에 의하여 마늘을 숙성시키는 방법이 발달되어져 왔다. 고온의 간접열에 의한 마늘 숙성은 마늘 특유의 불쾌한 냄새와 매운 맛을 없애고 달콤한 맛을 내고, 아미노산 등의 생체 이용률을 높인다.
Therefore, a method of ripening garlic by dry heat, which is an indirect heating method, has been developed. Garlic aging by high temperature indirect heat eliminates the unpleasant smell and spicy taste peculiar to garlic, gives sweet taste, and increases bioavailability of amino acids.
바실러스 속 미생물을 이용하여 배양한 흑마늘 발효액을 함유하는 화장료 조성물(특허출원2006-0116341); 효소를 이용한 발효 숙성 흑마늘의 제조방법(특허등록 10-0880268); 천연 산야초 발효 흑마늘, 그 제조방법 및 그것을 포함하는 건강식품(특허출원2006-0116341) 등이 있지만 식품이 아니거나 생마늘을 흑마늘로 숙성 시킬 때 효소를 이용하는 정도에 지나지 않는 것으로 식물성유산균을 이용하는 본 발명과는 기술적 사상이 다르다고 볼 것이다.Cosmetic composition containing a black garlic fermentation broth cultured using Bacillus microorganisms (Patent application 2006-0116341); Fermented ripening black garlic production method using an enzyme (Patent registration 10-0880268); Natural wild vinegar fermented black garlic, a method of manufacturing the same, and a health food containing the same (patent application 2006-0116341) and the like, but it is not a food or only to the extent of using an enzyme when aging raw garlic with black garlic, The technical idea is different.
상기 배경기술에 기재한 바와 같이 간접적으로 열을 가하는 방식인 건조열에 의하여 마늘을 숙성시키는 방법은 계속적으로 발전되어 왔다. 그러나 고온의 간접 열에 의한 숙성마늘은 숙성시간, 건조시간, 후처리시간 등의 완성 기간이 대부분 약 15일 이상이 걸리는 것이 일반적이라는 문제점이 있었다.As described in the background art, a method of ripening garlic by dry heat, which is an indirect heating method, has been continuously developed. However, the aging garlic by the high temperature indirect heat has a problem that the completion period of the ripening time, drying time, post-treatment time, etc. takes about 15 days or more in general.
숙성마늘이라도 후처리를 하지 않을 경우 마늘이 갖고 있는 특유의 향과 맛, 식감이 좋지 않은 문제점을 갖게 된다. 그러므로 후처리까지 걸리는 시간이 15일 이상의 시간이 필요한 것이 일반적이라는 문제점도 있었다.
Even if aged garlic is not treated, garlic has its own unique aroma, taste, and texture. Therefore, there was a problem that it is common to require a time of 15 days or more until the post-treatment.
한편 흑마늘의 자체숙성에 관한 내용은 다수 제안되어 왔으나, 미생물을 이용한 2차 발효에 대한 기술개발이 필요하다고 할 것이다.On the other hand, the contents of self-maturation of black garlic have been proposed, but it is necessary to develop technology for the secondary fermentation using microorganisms.
즉, 본 발명은 식물성유산균을 이용하여 발효흑마늘을 제조하는데 소요되는 시간을 단축하고, 나아가 다양한 건강에 유리한 기능성 물질을 첨가된 발효흑마늘을 만드는데 목적이 있다.
That is, the present invention aims to shorten the time required to prepare fermented black garlic using vegetable lactic acid bacteria, and furthermore, to make fermented black garlic to which various functional substances beneficial to health are added.
본 발명이 이루고자 하는 기술적 과제들은 이상에서 언급한 기술적 과제들로 제한되지 않으며, 언급되지 않은 또 다른 기술적 과제들은 본 발명의 기재로부터 당해 분야에서 통상의 지식을 가진 자에게 명확하게 이해될 수 있을 것이다.The technical objects to be achieved by the present invention are not limited to the above-mentioned technical problems, and other technical subjects which are not mentioned can be clearly understood by those skilled in the art from the description of the present invention .
상기 종래기술의 문제점과 과제를 해결하기 위해 본 발명에서는 본 발명은 (a) 마늘에서 마늘의 외피 및 마늘의 내피를 제거하는 단계; (b) 상기 마늘의 외피 및 마늘의 내피가 제거된 마늘을 파쇄하는 단계; (c) 상기 파쇄된 마늘의 수분이 65%~75%가 되도록 수분을 조절하는 단계; (d) 상기 수분이 조절된 마늘을 밀봉용기에 넣어 밀봉하는 단계; (e) 상기 밀봉된 마늘을 60℃~90℃의 건조기에서 숙성시키는 단계; (f) 상기 숙성된 마늘에 상기 숙성된 마늘의 중량 대비 2배~10배 가수하고, 분쇄하여 흑마늘액을 제조하는 단계; (g) 상기 흑마늘액을 80℃~90℃에서 고온살균하는 단계; (h) 상기 살균된 흑마늘액에 효모추출물 및 미네랄을 첨가하는 단계; (i) 상기 효모추출물 및 미네랄이 첨가된 흑마늘액에 식물성유산균을 접종한 후, 37℃~45℃에서 발효시키는 단계; (j) 상기 발효된 흑마늘액을 -68℃~-80℃에서 동결하여 진공건조하는 단계; (k) 상기 건조된 발효흑마늘을 파쇄하여 분말화하는 단계;를 포함하는 것을 특징으로 하는 식물성유산균을 이용한 효모추출물 및 미네랄을 함유하는 발효흑마늘의 제조방법 및 상기 방법에 의해 제조된 발효흑마늘을 제공한다.In order to solve the problems and problems of the prior art, the present invention includes the steps of (a) removing the outer skin of garlic and the inner skin of garlic from garlic; (b) crushing garlic in which the outer skin of garlic and the inner skin of garlic are removed; (c) adjusting the moisture so that the water of the crushed garlic becomes 65% to 75%; (d) sealing the moisture-controlled garlic in a sealed container; (e) aging the sealed garlic in a dryer at 60 ℃ ~ 90 ℃; (f) hydrolyzing 2 to 10 times the weight of the aged garlic to the aged garlic, and grinding to prepare black garlic solution; (g) sterilizing the black garlic solution at 80 ° C to 90 ° C; (h) adding yeast extract and mineral to the sterilized black garlic solution; (i) inoculating the vegetable lactic acid bacteria to the black garlic solution to which the yeast extract and the mineral are added, and then fermenting at 37 ° C. to 45 ° C .; (j) freezing the fermented black garlic solution at -68 ℃ ~ -80 ℃ vacuum drying; (k) crushing the dried fermented black garlic to powder the yeast extract and minerals using the phyto-lactic acid bacteria, characterized in that it comprises a; and provides a fermented black garlic prepared by the method do.
상기 배경기술에 기재한 바와 같이 간접적으로 열을 가하는 방식인 건조열에 의하여 마늘을 숙성시키는 방법은 계속적으로 발전되어 왔다. 그러나 고온의 간접 열에 의한 숙성마늘은 숙성시간, 건조시간, 후처리시간 등의 완성 기간이 대부분 약 15일 이상이 걸리는 것이 일반적이라는 문제점이 있었다.
As described in the background art, a method of ripening garlic by dry heat, which is an indirect heating method, has been continuously developed. However, the aging garlic by the high temperature indirect heat has a problem that the completion period of the ripening time, drying time, post-treatment time, etc. takes about 15 days or more in general.
숙성마늘이라도 후처리를 하지 않을 경우 마늘이 갖고 있는 특유의 향과 맛, 식감이 좋지 않은 문제점을 갖게 된다. 그러므로 후처리까지 걸리는 시간이 15일 이상의 시간이 필요한 것이 일반적이라는 문제점도 있었다.
Even if aged garlic is not treated, garlic has its own unique aroma, taste, and texture. Therefore, there was a problem that it is common to require a time of 15 days or more until the post-treatment.
한편 흑마늘의 자체숙성에 관한 내용은 다수 제안되어 왔으나, 미생물을 이용한 2차 발효에 대한 기술개발이 필요하다고 할 것이다.On the other hand, the contents of self-maturation of black garlic have been proposed, but it is necessary to develop technology for the secondary fermentation using microorganisms.
즉, 본 발명은 식물성유산균을 이용하여 발효흑마늘을 제조하는데 소요되는 시간을 단축하고, 나아가 다양한 건강에 유리한 기능성 물질을 첨가된 발효흑마늘을 만드는데 목적이 있다.
That is, the present invention aims to shorten the time required to prepare fermented black garlic using vegetable lactic acid bacteria, and furthermore, to make fermented black garlic to which various functional substances beneficial to health are added.
그러나 본 발명에서는 흑마늘을 만드는데 걸리는 시간과 발효시키는 시간을 합쳐 완성기간이 3일에서 9일정도의 시간 내 가능하도록 하였다. 흑마늘을 발효하게 되면 즉 2차 발효를 하게 되면 건조 및 후처리를 할 필요가 없으므로 완성까지 걸리는 시간을 많이 단축하게 된다.
However, in the present invention, the time required for making black garlic and the time for fermentation are combined to allow a completion period of about 3 to 9 days. When fermented black garlic, that is, secondary fermentation, it does not need to be dried and post-processed, thereby greatly reducing the time required for completion.
또한 마늘의 다양 하고도 많은 유효한 성분뿐 아니라 식물성유산균의 유효한 생산물질 및 식물성유산균 자체의 기능성을 포함하고 있는 제품을 만들 수 있다.
In addition, it is possible to produce a product containing not only a variety of active ingredients of garlic, but also an effective production material of phyto-lactic acid bacteria and the functionality of phyto-lactic acid bacteria themselves.
본 발명의 제조 방법에 의하여 제조된 발효 흑마늘은 기존의 흑마늘이 가지고 있는 유효성분과 이들 성분을 포함한 흑마늘을 식물성유산균의 발효에 의한 생산물질의 기능성 및 유산균자체의 기능성을 포함하고 있어 이런 여러 기능성분이 인체에 탁월한 효능을 발휘할 것으로 종래기술의 문제점을 극복하는 유리한 효과가 있다고 할 것이다.Fermented black garlic prepared by the manufacturing method of the present invention contains the active ingredient of the existing black garlic and the black garlic including these components of the production material by the fermentation of plant lactic acid bacteria and the functionality of the lactic acid bacteria itself, these various functional ingredients It will be said that there is an advantageous effect to overcome the problems of the prior art to exhibit excellent efficacy.
도 1은 흑마늘의 70% EtOH 추출물의 EDA(electron donating ability)의 변화를 나타낸 그래프이다. 첫번째 막대그래프는 시료의 농도가 20mg/ml인 것을 나타내고, 두번째 막대그래프는 시료의 농도가 10mg/ml인 것을 나타내며, 세번째 막대그래프는 시료의 농도가 5mg/ml인 것을 나타내고, 네번째 막대그래프는 시료의 농도가 1mg/ml인 것을 나타낸다.
도 2는 흑마늘의 70% EtOH 추출물의 환원력(Reducing power)를 나타낸 그래프이다. 첫번째 막대그래프는 시료의 농도가 20mg/ml인 것을 나타내고, 두번째 막대그래프는 시료의 농도가 10mg/ml인 것을 나타내며, 세번째 막대그래프는 시료의 농도가 1mg/ml인 것을 나타낸다.
도 3은 흑마늘의 70% EtOH 추출물의 총 폴리페놀 함량(Total polyphenol contents)의 측정결과이다.
도 4는 흑마늘의 70% EtOH 추출물의 총 플라보노이드 함량(Total flavonoid contents)의 측정결과이다.
도 5는 흑마늘의 70% EtOH 추출물의 지질의 자동산화 저해활성(Anti-lipid peroxidation activities) 실험에 관한 그래프이다.
도 6은 흑마늘의 70% EtOH 추출물의 a-glucosidase에 대한 저해 활성에 대한 그래프이다.
도 7은 흑마늘의 70% EtOH 추출물의 림프구의 ATK 유도활성(in vivo/in vitro)측정에 대한 데이터(Immune effects of extracts from fermented black garlic)를 그래프로 나타내었다. M1은 Control로 Black garlic control이고, M2는 Inoculation으로 In whole black garlic inoculation이며, M3는 Fermentation으로 After peeling of black garlic, fermentation이고, M5는 F.D.로 After black garlic fermentation, freeze drying한 것을 나타낸다.
도 8은 일반 마늘의 70% EtOH 추출물의 림프구의 ATK 유도활성(in vivo/in vitro)측정에 대한 데이터를 그래프로 나타내었다.
도 9는 Scheme of autologous tumor-killing activity에 관한 것이다.1 is a graph showing the change in electron donating ability (EDA) of 70% EtOH extract of black garlic. The first bar graph shows the sample concentration is 20 mg / ml, the second bar graph shows the sample concentration is 10 mg / ml, the third bar graph shows the sample concentration is 5 mg / ml, and the fourth bar graph shows the sample concentration. It shows that the concentration of 1 mg / ml.
Figure 2 is a graph showing the reducing power (Reducing power) of 70% EtOH extract of black garlic. The first bar graph shows the sample concentration is 20 mg / ml, the second bar graph shows the sample concentration is 10 mg / ml, and the third bar graph shows the sample concentration is 1 mg / ml.
Figure 3 is a measurement of the total polyphenol content (Total polyphenol contents) of 70% EtOH extract of black garlic.
Figure 4 is the result of measuring the total flavonoid contents (Total flavonoid contents) of 70% EtOH extract of black garlic.
FIG. 5 is a graph illustrating anti-lipid peroxidation activities of lipids of 70% EtOH extract of black garlic.
6 is a graph showing the inhibitory activity against a-glucosidase of 70% EtOH extract of black garlic.
Figure 7 graphically shows the data (Immune effects of extracts from fermented black garlic) for measuring ATK-induced activity ( in vivo / in vitro ) of lymphocytes of 70% EtOH extract of black garlic. M1 is Black garlic control with Control, M2 is In whole black garlic inoculation with Inoculation, M3 is After peeling of black garlic and fermentation with Fermentation, M5 is After black garlic fermentation and freeze drying with FD.
8 is a graph showing the data for the ATK induced activity ( in vivo / in vitro ) measurement of lymphocytes of 70% EtOH extract of normal garlic.
9 relates to the scheme of autologous tumor-killing activity.
본 발명은 (a) 마늘에서 마늘의 외피 및 마늘의 내피를 제거하는 단계; (b) 상기 마늘의 외피 및 마늘의 내피가 제거된 마늘을 파쇄하는 단계; (c) 상기 파쇄된 마늘의 수분이 65%~75%가 되도록 수분을 조절하는 단계; (d) 상기 수분이 조절된 마늘을 밀봉용기에 넣어 밀봉하는 단계; (e) 상기 밀봉된 마늘을 60℃~90℃의 건조기에서 숙성시키는 단계; (f) 상기 숙성된 마늘에 상기 숙성된 마늘의 중량 대비 2배~10배 가수하고, 분쇄하여 흑마늘액을 제조하는 단계; (g) 상기 흑마늘액을 80℃~90℃에서 고온살균하는 단계; (h) 상기 살균된 흑마늘액에 효모추출물 및 미네랄을 첨가하는 단계; (i) 상기 효모추출물 및 미네랄이 첨가된 흑마늘액에 식물성유산균을 접종한 후, 37℃~45℃에서 발효시키는 단계; (j) 상기 발효된 흑마늘액을 -68℃~-80℃에서 동결하여 진공건조하는 단계; (k) 상기 건조된 발효흑마늘을 파쇄하여 분말화하는 단계;를 포함하는 것을 특징으로 하는 식물성유산균을 이용한 효모추출물 및 미네랄을 함유하는 발효흑마늘의 제조방법 및 상기 방법에 의해 제조된 발효흑마늘에 관한 것이다.
The present invention comprises the steps of (a) removing the outer skin of garlic and the inner skin of garlic from garlic; (b) crushing garlic in which the outer skin of garlic and the inner skin of garlic are removed; (c) adjusting the moisture so that the water of the crushed garlic becomes 65% to 75%; (d) sealing the moisture-controlled garlic in a sealed container; (e) aging the sealed garlic in a dryer at 60 ℃ ~ 90 ℃; (f) hydrolyzing 2 to 10 times the weight of the aged garlic to the aged garlic, and grinding to prepare black garlic solution; (g) sterilizing the black garlic solution at 80 ° C to 90 ° C; (h) adding yeast extract and mineral to the sterilized black garlic solution; (i) inoculating the vegetable lactic acid bacteria to the black garlic solution to which the yeast extract and the mineral are added, and then fermenting at 37 ° C. to 45 ° C .; (j) freezing the fermented black garlic solution at -68 ℃ ~ -80 ℃ vacuum drying; (k) pulverizing the dried fermented black garlic powder; and a method for producing a fermented black garlic containing yeast extract and mineral using a vegetable lactic acid bacterium, and the fermented black garlic prepared by the method will be.
이하에서 첨부된 도면을 참조한 실시예에 의거하여 구체적으로 설명한다.
Hereinafter, the present invention will be described in detail with reference to the accompanying drawings.
[실시예 1] 식물성유산균을 이용한 효모추출물 및 미네랄을 함유하는 발효흑마늘의 제조
Example 1 Preparation of Fermented Black Garlic Containing Yeast Extract and Mineral Using Vegetable Lactic Acid Bacteria
마늘에서 마늘의 외피 및 마늘의 내피를 깨끗이 제거한 후에 파쇄하였다. 상기 파쇄된 마늘의 수분이 65%~75%가 되도록 수분을 조절한 후에 용기에 넣어 밀봉하였다. 상기 밀봉된 마늘을 60℃~90℃의 건조기에서 숙성시켰다. Garlic and garlic was completely removed from the garlic and then crushed. The moisture of the crushed garlic was sealed in a container after adjusting the moisture to 65% ~ 75%. The sealed garlic was aged in a dryer at 60 ° C ~ 90 ° C.
다음으로 상기 숙성된 마늘에 상기 숙성된 마늘의 중량 대비 2배~10배 가수하고, 분쇄하여 흑마늘액을 제조한 후에 상기 흑마늘액을 80℃~90℃에서 고온살균하였다.Next, the aged garlic was hydrolyzed 2 to 10 times compared to the weight of the aged garlic, and pulverized to prepare a black garlic solution, and then the black garlic solution was sterilized at 80 ° C. to 90 ° C. at high temperature.
그리고 상기 살균된 흑마늘액에 효모추출물 및 미네랄을 첨가한 후에 상기 효모추출물 및 미네랄이 첨가된 흑마늘액에 식물성유산균을 접종 하였다.
After the yeast extract and the mineral were added to the sterilized black garlic solution, the lactic acid bacteria were inoculated into the yeast extract and the black garlic solution to which the mineral was added.
상기 효모추출물은 네덜란드의 DSM사(http://www.dsm.com/)에서 판매하는 효모추출물을 사용하였다.
The yeast extract was used as a yeast extract sold by DSM of the Netherlands ( http://www.dsm.com / ).
상기 미네랄은 칼슘(Ca), 인(P), 망간(Mg), 황(S), 소디움(Na), 칼륨(K), 염소(Cl), 철(Fe), 아연(Zn), 구리(Cu), 요오드(I), 불소(F), 셀레늄(Se), 망간(Mn), 크롬(Cr) 및 몰리브덴(Mo)으로 이루어진 군으로부터 선택된 어느 하나 이상일 수 있다.
The minerals are calcium (Ca), phosphorus (P), manganese (Mg), sulfur (S), sodium (Na), potassium (K), chlorine (Cl), iron (Fe), zinc (Zn), copper ( Cu), iodine (I), fluorine (F), selenium (Se), manganese (Mn), chromium (Cr) and molybdenum (Mo) may be any one or more selected from the group consisting of.
다음으로 37℃~45℃에서 48시간~52시간 유산균에 의한 발효를 시킨 후 상기 발효된 흑마늘액을 -68℃~-80℃에서 동결하여 진공건조 하였다.
Next, after fermentation by lactic acid bacteria for 48 hours to 52 hours at 37 ℃ ~ 45 ℃, the fermented black garlic solution was frozen at -68 ℃ ~ -80 ℃ and vacuum dried.
상기 식물성 유산균은 락토바실러스 퍼멘텀(Lactobacillus fermentum JS, 특허등록번호 0435168, 특허균주기탁번호 KCCM10499), 락토바실러스 플란타럼(Lactobacillus plantarum), 락토바실러스 델브뤽키(L. delbruckii), 락토바실러스 카제이(L. casei), 락토바실러스 브레비스(L. brevis), 류코노스톡 메센테로이데스(Leuconostoc mesenteroides), 페디오코커스 애시디락티시(Pediococcus acidilactici) 및 스트렙토코쿠스 락티스(Streptococcus lactis)으로 이루어진 군으로부터 선택된 어느 하나일 수 있다.
The plant lactic acid bacteria are Lactobacillus fermentum JS (patent registration number 0435168, patent cycle number KCCM10499), Lactobacillus plantarum ( Lactobacillus plantarum ), Lactobacillus delbruckii ( L. delbruckii), Lactobacillus casei ( L. casei, L. brevis, Leuconostoc mesenteroides, Pediococcus acidilactici and Streptococcus lactis It may be any one selected.
그리고 상기 건조된 발효흑마늘을 파쇄하여 분말화함으로써 식물성유산균을 이용한 효모추출물 및 미네랄을 함유하는 발효흑마늘을 제조하였다.
Then, the dried fermented black garlic was crushed and powdered to prepare a fermented black garlic containing yeast extract and mineral using plant lactic acid bacteria.
[실시예 2] 식물성유산균을 접종한 발효흑마늘의 유산균수 측정
Example 2 Measurement of Lactic Acid Bacteria in Fermented Black Garlic Inoculated with Vegetable Lactic Acid Bacteria
실시예 1의 방법으로 제조된 식물성유산균을 이용한 효모추출물 및 미네랄을 함유하는 발효흑마늘의 유산균수와 pH를 측정하여 하기의 [표 1]에 나타내었다.
The lactic acid bacteria number and pH of the fermented black garlic containing the yeast extract and minerals prepared by using the method of the plant lactic acid bacteria prepared in Example 1 are shown in Table 1 below.
실험방법: Experimental Method:
1. 유산균수 측정1. Measurement of Lactic Acid Bacteria
(1) BCP 첨가 평판측정용 한천배지(Plate Count Agar with Brom Cresol Purple)(1) Plate Count Agar with Brom Cresol Purple
Yeast Extract 2.5gYeast Extract 2.5g
Peptone 5.0gPeptone 5.0g
Dextrose 1.0gDextrose 1.0g
Tween 80 1.0g
L-Cysteine 0.1gL-Cysteine 0.1g
Agar 15.0gAgar 15.0 g
위의 성분을 증류수 1,000mL에 녹여 pH 6.8-7.0으로 조정한 후 BCP(Brom cresol purple)을 0.004-0.006%가 되도록 가하고 121에서 15분간 멸균한다.
Dissolve the above components in 1,000 mL of distilled water to adjust the pH to 6.8-7.0, add BCP (Brom cresol purple) to 0.004-0.006% and sterilize at 121 for 15 minutes.
(2) 검체의 채취 및 시험용액의 조제 (2) Sampling and preparation of test solution
(가) 일반적인 주의사항으로는 검체를 무균적으로 취급한다. (A) As a general precaution, treat samples aseptically.
(나) 본 실험에 사용한 분말상 검체 : 검체를 멸균유리봉과 멸균스파테르 등으로 잘 혼합한 후 그 일정양(10g)을 멸균용기에 취해 9배 양의 멸균생리식염수(0.85%)와 혼합한 것을 시험용액으로 한다.
(B) Powdered specimens used in this experiment: After mixing the specimens well with sterile glass rods and sterile spatters, take a certain amount (10g) in a sterile container and mix it with 9 times sterile physiological saline solution (0.85%). Test solution is used.
(3) 희석배수 (3) dilution factor
(가) 조제된 시험 원액(10-1)에 대해서는 멸균생리 식염수를 이용하여 예상되는 균수에 따라 희석액을 10배(10-2), 100배(10-3), 1,000배(10-4), 10,000배(10-5) 100,000배(10-6) 등으로 만들어 사용한다.(A) For the prepared test stock (10 -1 ), dilute the
(4) 측정 방법 (4) measuring method
(가) '나'의 시험용액 1mL와 각 단계 희석액 1mL씩을 멸균 페트리디쉬(petri dish 지름 9-10cm, 높이 1.5cm) 2매 이상씩에 무균적으로 취하여 약 43-45로 유지한 '가'의 BCP 첨가 평판측정용 한천배지 약 15mL를 무균적으로 분주하고 페트리디쉬 뚜껑에 부착하지 않도록 주의하면서 조용히 회전하여 좌우로 기울이면서 검체와 배지를 잘 섞고 냉각 응고시킨다. (A) Take 1 ml of test solution and 1 ml of each dilution of each step aseptically in 2 or more sheets of sterile Petri dish (9-10cm in diameter, 1.5cm in height) and keep it at about 43-45. Dispense about 15mL of agar plate for BCP plated aseptic aseptically and rotate it gently while tilting it to the left and right while being careful not to attach it to the Petri dish lid.
(나) 냉각 응고시킨 페트리디쉬는 거꾸로 하여 35℃-37℃에서 1~3일 배양한 후 발생한 황색의 집락(colony)을 유산균의 집락으로 계측한다. (B) Cooled and solidified Petri dishes are inverted and cultured for 1 to 3 days at 35 ° C-37 ° C. The yellow colony is measured as a colony of lactic acid bacteria.
(다) 집락수의 계산은 1평판당(petri dish) 30개~300개의 집락을 생성한 평판을 택하여 집락수를 계산하는 것을 원칙으로 한다. (C) In principle, the number of colonies shall be calculated by taking the plates from which 30 to 300 colonies are produced per petri dish.
(라) 전 평판에 300개 이상 집락이 발생한 경우 300개에 가까운 평판에 대하여 밀집평판 측정법에 따라 안지름 9cm의 페트리디쉬인 경우에는 1cm2내의 평균집락수에 65를 곱하여 그 평판의 집락수로 계산한다. (D) When 300 or more colonies occur on all plates, the average number of colonies within 1 cm 2 is calculated by multiplying 65 by the average number of colonies within 1 cm 2 according to the dense flat plate measurement method. do.
(마) 전 평판에 30개 이하의 집락만을 얻었을 경우에는 가장 희석배수가 얕은 것을 측정한다.
(E) Where only 30 colonies are obtained on the plate, the lowest dilution factor is measured.
2. pH측정은 최종 제품의 시료 10g에 증류수 90mL을 넣고 균질기로 마쇄한 후 pH meter(ORION 3STAR pH Benchtop, USA)로 측정하였다. 2. The pH was measured in a pH meter (ORION 3STAR pH Benchtop, USA) after adding 90 mL of distilled water to a 10g sample of the final product and milled with a homogenizer.
항목sample
Item
[실시예 3] EDA(electron donating ability) 실험
Example 3 Electron donating ability (EDA) experiment
실험방법: 흑마늘 추출물의 전자공여능(electron donating ability, EDA)은 Shimada et al., 1992의 방법을 변형하여 측정하였다. DPPH 59.148 을 absolute methanol 1l에 용해하여 0.15mM의 용액을 제조한 다음 methanol를 blank로 하여 517 nm에서 UV-visivle spectrophotometer로 흡광도를 측정한 후 sample 첨가구와 sample 대신 methanol를 첨가한 무 첨가구의 흡광도 차이를 백분율(%)로 표시하여 전자공여능을 측정하였으며 아래와 같이 계산하였다.Experimental Method: Electron donating ability (EDA) of black garlic extract was measured by modifying the method of Shimada et al ., 1992. After dissolving DPPH 59.148 in 1 l of absolute methanol to prepare a 0.15 mM solution, the absorbance was measured by UV-visivle spectrophotometer at 517 nm with methanol as blank, and then the absorbance difference between the sample and the sample-free methanol was added. The electron donating ability was measured as a percentage (%) and calculated as follows.
EDA (%) = (1-absorbance value of sample/absorbance value of control)×100
EDA (%) = (1-absorbance value of sample / absorbance value of control) × 100
실험결과: 흑마늘의 70% EtOH 추출물의 전자공여능(EDA)을 측정한 결과는 도 1에서 보는 바와 같이 시료의 농도가 증가할수록 전자공여능 활성이 증가하는 경향을 나타내었다.Experimental results: As a result of measuring the electron donating ability (EDA) of the 70% EtOH extract of black garlic showed that the electron donating activity increased as the concentration of the sample increases.
시료의 농도가 20mg/ml, 10mg/ml, 5mg/ml, 1mg/ml 인 경우에 F.D.(흑마늘 발효 시킨 후 동결건조한 샘플)가 각각 82%, 70.5%, 38.9%, 9.0%로 다른 방법보다 유의적으로(p<0.05) 더 높은 전자공여능 수치를 나타내었다.When the sample concentration was 20mg / ml, 10mg / ml, 5mg / ml, 1mg / ml, FD (freeze-dried sample after black garlic fermentation) was 82%, 70.5%, 38.9% and 9.0%, respectively. As a result (p <0.05), the electron donating ability was higher.
상기 전자공여능 수치가 높은 것은 항산화 물질이 많다는 것을 의미한다.
High electron donating ability means that there are many antioxidants.
[실시예 4] 환원력(Reducing power)측정 실험
Example 4 Reducing power measurement experiment
실험방법: Oyaizu의 방법(1986)을 변형하여 측정하였다. 흑마늘 추출물을 농도별로 조제하여 100 를 첨가한 후 0.2M sodium phosphate 버퍼(pH 6.6) 500 ml와 1% potassium ferricyanide 500 ml를 첨가한 후 50 ℃에서 20 분간 pre-incubation 시킨 후 10% trichloroacetic acid(v/v) 2.5 ml 가한 후 10분 동안 원심분리 하여 얻은 상층액 500 ml를 취하여 distill water 500 ml 를 가한 후 1% ferric chloride를 100 ml를 혼합하여 즉시 흡광도 700 nm에서 측정하였다. 시료의 환원력은 흡광도의 값으로 나타내었다.
Experimental Method: Measured by modifying Oyaizu's method (1986). Black garlic extract was prepared by concentration, and then 100 was added, followed by 500 ml of 0.2M sodium phosphate buffer (pH 6.6) and 500 ml of 1% potassium ferricyanide, followed by pre-incubation for 20 minutes at 50 ℃, followed by 10% trichloroacetic acid (v / v) 500 ml of the supernatant obtained by centrifugation for 10 minutes after 2.5 ml was added, and 500 ml of distill water was added, and 100 ml of 1% ferric chloride was immediately measured at 700 nm. The reducing power of the sample was expressed as a value of absorbance.
실험결과: 흑마늘의 70% EtOH 추출물의 흑마늘의 70% EtOH 추출물의 환원력(Reducing power)측정 실험을 수행하였다. 보다 구체적으로는 흑마늘을 첨가한 후 금속이온을 환원시키는 환원력을 측정한 결과를 도 2에 나타내었다.
Experimental Results: Reducing power of 70% EtOH extract of black garlic was measured. More specifically, the results of measuring the reducing power of reducing metal ions after adding black garlic are shown in FIG. 2.
환원력은 노화방지에 관계가 있으며, 시료의 농도가 점차적으로 증가함에 따라 환원력이 증가하는 경향을 보였으며 20mg/ml, 10mg/ml, 1mg/ml 농도의 F.D.(흑마늘 발효 시킨 후 동결건조한 샘플)가 각각 0.87, 0.52, 0.29로 다른 방법보다 유의적으로(p<0.05) 더 높은 활성을 나타내는 것으로 나타났다.Reducing power is related to anti-aging, and the reducing power tended to increase as the concentration of the sample was gradually increased. 0.87, 0.52 and 0.29, respectively, were found to be significantly higher than other methods (p <0.05).
따라서 본 발명인 식물성유산균을 이용한 효모추출물 및 미네랄을 함유하는 발효흑마늘에는 노화방지 기능성이 있다고 사료된다.
Therefore, the fermented black garlic containing yeast extract and mineral using the plant lactic acid bacteria of the present invention is considered to have anti-aging function.
[실시예 5] 총 폴리페놀 함량(Total polyphenol contents)의 측정
Example 5 Measurement of Total Polyphenol Contents
실험방법: 흑마늘 추출물의 총 폴리페놀 함량은 Folin-Ciocalteau 방법(Singleton & Rossi, 1965)을 사용하였다. 즉 희석한 시료에 Folin-Ciocalteu 시약 50 를 가하여 혼합하고 3분 후 20% sodium carbonate(Na2CO3) 300 ml를 넣어 15분 안정화 시킨 후 1 ml dH2O 첨가한 후 UV-vis spectrophotometer를 사용하여 725 nm에서 흡광도를 측정하였다. 표준물질로 gallic acid를 사용하여 작성된 표준 건량 곡선으로부터 페놀화합물을 정향하여 GAE(Gallic Acid Equivalents)로 나타내었다.
Experimental Method: The total polyphenol content of black garlic extract was Folin-Ciocalteau method (Singleton & Rossi, 1965). In other words, Folin-
실험결과: 흑마늘의 70% EtOH 추출물의 총 폴리페놀 함량을 측정하여, 그 결과를 도 3에 나타내었다. 총 폴리페놀 함량은 F.D.가 0.16 ( GAE/g)으로 다른 시험군에 비해 유의적으로(p<0.05) 가장 높게 나타났다.Experimental Results: The total polyphenol content of 70% EtOH extract of black garlic was measured, and the result is shown in FIG. 3. The total polyphenol content of F.D. was 0.16 (GAE / g), which was significantly higher than other test groups (p <0.05).
폴리페놀 물질은 과실, 채소, 곡물 등 다양한 식품에 함유되어 있는 기능성 물질로 항산화, 항알레르기, 항암, 항염증 효과 등 다양한 생물학적 활성으로 인해 각광받고 있는 물질이다. 특히 활성산소로 인해 생기는 산화스트레스는 알츠하이머까지 연관되는 것으로 알려져 있는데, 페놀물질은 이러한 산화스트레스로부터 보호하는 항산화효과가 뛰어난 것으로 알려져 있다.
Polyphenols are functional substances contained in various foods such as fruits, vegetables, and grains, and are attracting attention due to various biological activities such as antioxidant, anti-allergic, anti-cancer, and anti-inflammatory effects. In particular, oxidative stress caused by active oxygen is known to be linked to Alzheimer's, phenolic material is known to have an excellent antioxidant effect to protect against this oxidative stress.
따라서 F.D.가 항산화, 항알레르기 등의 기능성이 가장 우수한 것으로 사료되었다.
Therefore, FD was considered to be the most functional such as antioxidant and anti-allergic.
[실시예 6] 총 플라보노이드 함량(Total flavonoid contents)의 측정
Example 6 Measurement of Total Flavonoid Contents
실험방법: 총 플라보노이드 함량은 Moreno 등의 방법(2000)을 변형하여 측정하였다. 추출물 500 ml에 10% aluminum Nitrate 시약 100 를 가하여 혼합하고 1M potassium acetate 100 ml, 80% EtOH 4.3 ml 반응시킨 후 40분 동안 실온에서 안정화시킨 후 UV-vis spectrophotometer를 사용하여 415 nm에서 흡광도를 측정하였다. 실험을 통하여 얻어진 결과는 표준물질로 quercetin를 사용하여 작성된 표준 검량 곡선으로부터 flavonoid화합물을 정량하여 검량 곡선으로 나타내었다.
Experimental Method: The total flavonoid content was measured by modifying the method of Moreno et al. (2000). 100 ml of 10% aluminum Nitrate reagent was added to 500 ml of the extract, mixed with 100 ml of 1M potassium acetate and 4.3 ml of 80% EtOH, and then stabilized at room temperature for 40 minutes. The absorbance was measured at 415 nm using a UV-vis spectrophotometer. . The results obtained through the experiments were shown as calibration curves by quantifying flavonoid compounds from standard calibration curves prepared using quercetin as a standard.
실험결과: 흑마늘의 70% EtOH 추출물의 총 플라보노이드 함량을 측정하여, 그 결과를 도 4에 나타내었다. 총 플라보노이드 함량은 F.D.가 0.0043 ( GAE/g)으로 다른 시험군에 비해 유의적으로(p<0.05) 가장 높게 나타났다.
Experimental Results: The total flavonoid content of 70% EtOH extract of black garlic was measured, and the result is shown in FIG. 4. The total flavonoid content was 0.0043 (GAE / g), which was significantly higher than other test groups (p <0.05).
플라보노이드란 식품에 널리 분포하는 노란색 계통의 색소로, 페닐기 2개가 C3사슬을 매개하여 결합한 탄소골격구조로 되어 있다. 산성에서는 안전하여 색이 더욱 선명해지지만, 강한 알칼리에서는 그 구조가 변하여 짙은 노란색이나 갈색으로 변한다.
Flavonoids are yellow pigments widely distributed in foods and have a carbon skeleton structure in which two phenyl groups are bonded through a C 3 chain. It is safe in acid, so the color becomes clearer, but in strong alkali, its structure changes to dark yellow or brown.
플라보노이드는 항균?항암?항바이러스?항알레르기 및 항염증 활성을 지니며, 독성은 거의 나타나지 않는 것으로 보고되고 있다. 또한 모든 질병의 원인이 되는 생체 내 산화작용을 억제한다는 사실이 알려지면서 플라보노이드계 물질의 개발 및 활용에 관한 관심이 지속적으로 커지고 있는 실정이다.Flavonoids have been reported to have antimicrobial, anticancer, antiviral, antiallergic and anti-inflammatory activities, with little toxicity. In addition, as the fact that it inhibits the oxidation in vivo which causes all diseases is known that the interest in the development and utilization of flavonoid-based material is continuously increasing.
따라서 F.D.가 항산화, 항알레르기 등의 기능성이 가장 우수한 것으로 사료되었다.
Therefore, FD was considered to be the most functional such as antioxidant and anti-allergic.
[실시예 7] 지질의 자동산화 저해활성(Anti-lipid peroxidation activities) 실험
Example 7 Anti-lipid Peroxidation Activities
실험방법: 지질의 자동산화 저해활성으로서의 항지질 과산화물가는 ferric thiocyanate법 (Inatani et al., 1983)으로 측정하였다. 시료를 1 mg/ml 농도로 조제하였다. 시료 20 ml를 취하여 ethanol에 희석한 2.5% linoleic acid 200 ml와 0.05M phosphate buffer(pH 7.0) 400 ml, water 380 ml를 차례대로 넣고 70 ℃ 암 조건에서 24시간 반응시킨다. 반응액 50 ml, 75% ethanol 2.85 ml, 30% ammonium thiocyanate 50 ml 와 3.5% HCl-0.02M ferrous chloride 50 ml를 혼합하여 상온에서 3분간 반응시킨 후 500 nm에서 흡광도를 측정하였다. sample 대신 water를 첨가한 sample 무첨가구는 blank로 사용하였으며 3반복 실행하였다. 대조군의 흡광도에 대한 저해율(%)로서 아래와 같이 계산하였다.Experimental method: Antilipid peroxide value as lipid oxidative inhibitory activity was measured by ferric thiocyanate method (Inatani et al ., 1983). Samples were prepared at a concentration of 1 mg / ml. Take 20 ml of the sample, add 200 ml of 2.5% linoleic acid diluted in ethanol, 400 ml of 0.05M phosphate buffer (pH 7.0), and 380 ml of water in order. 50 ml of reaction solution, 75 ml of 2.85 ml of ethanol, 50 ml of 30% ammonium thiocyanate and 50 ml of 3.5% HCl-0.02M ferrous chloride were mixed at room temperature for 3 minutes, and the absorbance was measured at 500 nm. The sample-free fixture with water instead of the sample was used as a blank and repeated three times. Inhibition rate (%) of the control group was calculated as follows.
Linoleic acid inhibition(%) = (1 - Sample OD/Blank OD) × 100
Linoleic acid inhibition (%) = (1-Sample OD / Blank OD) × 100
Sample OD : Absorbance of the experimental sampleSample OD: Absorbance of the experimental sample
Blank OD : Absorbance of the blank
Blank OD : Absorbance of the blank
실험결과: 흑마늘의 70% EtOH 추출물의 지질 자동산화 저해활성을 실험하여, 그 결과를 도 5에 나타내었다. Control, Inoculation, Fermentation, 간에 큰 차이를 보이지 않았으나 F.D.의 경우는 유의적으로(p<0.05) 다른 시험구에 비해 지질의 자동산화 저해활성 효과가 높았다.
Experimental Results: The lipid autooxidation inhibitory activity of 70% EtOH extract of black garlic was tested, and the results are shown in FIG. 5. There was no significant difference between control, inoculation, and fermentation, but FD showed a significantly higher (p <0.05) effect on the autooxidation inhibitory activity of lipids than the other groups.
[실시예 8] 항당뇨 활성(a-glucosidase 저해활성 측정법) 실험Example 8 Antidiabetic Activity (A-glucosidase Inhibition Activity Assay) Experiment
실험방법: a-glucosidase에 대한 저해 활성은 다음의 [표 2]와 같이 반응액을 제조하여 실시하였다.
Experimental method: The inhibitory activity against a-glucosidase was prepared by preparing a reaction solution as shown in Table 2 below.
(a-glucosidase)Enzyme
(a-glucosidase)
(D.W)100
(DW)
모든 반응이 종료되면 결과값은 405nm에서 흡광도를 측정하여 다음의 식에 대입하여 결과 값을 산출한다.
When all reactions are completed, the resultant is measured by absorbance at 405nm and substituted into the following formula to calculate the resultant.
Inhibitory rate(%)= Control-(Sample-Sample Blank)/Control
Inhibitory rate (%) = Control- (Sample-Sample Blank) / Control
a-glucosidase에 대한 일반적인 저해율은 그래프로 표시하며 시료의 ACE(Angiotensin Comverting Enzyme)저해율이 50%인 때의 농도를 IC50으로 나타낼 수 있다. IC50을 구하기 위해서는 여러농도에서 저해율 산출 후 농도와 저해율 간의 방정식(검량선을 구한 후 저해율 50%일 때의 시료농도를 산술적으로 구한다.
The general inhibition rate for a-glucosidase is represented graphically, and the concentration at the time of 50% ACE (Angiotensin Comverting Enzyme) inhibition rate can be expressed as IC 50 . To calculate the IC 50 , calculate the inhibition rate at various concentrations and calculate the arithmetic equation between the concentration and the inhibition rate.
실험결과: 흑마늘의 70% EtOH 추출물의 a-glucosidase에 대한 저해 활성에 대한 실험을 하여 그 결과를 도 6에 나타내었다.
Experimental Results: Experiments on the inhibitory activity against a-glucosidase of 70% EtOH extract of black garlic were shown in FIG. 6.
IC50값은 F.D.(흑마늘 발효 시킨 후 동결건조한 샘플)가 126.4±2.3 mg/ml로 유의적으로(p<0.05) 높은 저해 활성을 나타내었다.
IC 50 value of FD (freeze-dried samples after black garlic fermentation) was 126.4 ± 2.3 mg / ml significantly (p <0.05) showed a high inhibitory activity.
[실시예 9] 림프구의 ATK 유도활성(in vivo/in vitro)측정
Example 9 ATK Induction Activity of Lymphocytes ( in vivo / in vitro )
실험방법: ATK(Autologous Tumor-Killing Activity) 유도활성 측정은 인체의 면역력이 암, 성인병 등을 비롯한 각종 질환에 대하여 어느 정도의 면역력을 가지고 있는지를 측정하고, 인체의 면역력을 상승시킬 수 있는 소재를 찾을 수 있는 특징이 있다. 또한 최신 검사기기를 도입하여 개개인 인체의 면역력 측정을 정확히 수행하며 검사 data는 수치화, 그래프화 되기 때문에 인체 면역력의 높낮이를 구체적으로 파악할 수 있어 자신의 신체가 질환이나 성인병에 노출되어 있는지 등에 대한 구체적인 상태를 알 수 있다.
Experimental method: ATK (Autologous Tumor-Killing Activity) induction activity measurement measures the immunity of human body against various diseases including cancer, adult disease, etc. There are features to find. In addition, by introducing the latest test equipment, the individual's body immunity is measured accurately and the test data are quantified and graphed, so the specific level of human body's immunity can be grasped in detail. It can be seen.
본 실험은 혈액의 백혈구 중 하나인 림프구를 이용하여 면역력을 측정하고 유산균 발효 흑마늘에 대한 면역력에 미치는 영향을 측정하기 위하여 도 9의 방법에 따라 ATK(Autologous Tumor-Killing Activity) 유도활성을 이용하여 측정하였다.
This experiment was performed using ATK (Autologous Tumor-Killing Activity) inducing activity according to the method of FIG. 9 to measure immunity using lymphocytes, one of the white blood cells of blood, and to measure immunity against lactic acid bacteria fermented black garlic. It was.
ATK 유도 활성은 식품소재의 복용에 의해 어떻게 영향을 받는지 Picibanil(OK-432) 및 인터루킨2(IL-2)에 대한 반응도 동시에 측정하였다. 복용 검사에서는 유산균 발효 흑마늘 식품소재가 직접 또는 간접적으로 림프구를 활성화 하는지, 또 면역계 전체를 활성화 하는지의 여부를 골수성 백혈병 암 세포인 K562균주를 활용하여 측정한 결과를 도 7에 나타내었다.
ATK-induced activity was also affected by the use of foodstuffs and simultaneously measured responses to Picibanil (OK-432) and Interleukin 2 (IL-2). In the dosing test, the results of the measurement of the lactic acid bacteria fermented black garlic food material directly or indirectly to activate lymphocytes and to activate the entire immune system using the K562 strain of myeloid leukemia cancer cells are shown in FIG. 7.
실험결과 도 7에서 혈액형이 A인 해당자의 경우 Control구인 본인 자신의 면역력보다 유산균 발효 흑마늘 식품소재를 적용시 약 4%~20%의 면역력을 향상시키는 결과를 얻었으며, 특히 M3 시험구인 식물성유산균에 의한 발효흑마늘에서는 약 20%의 면역력 증강효과를 나타내었다. 따라서 전반적으로 식물성유산균 발효흑마늘 식품소재에 대하여 높은 면역력 향상 효과의 결과를 얻을 수 있었다.As a result of the experiment in FIG. 7, when the blood type is A, the immunity of the Lactobacillus fermented black garlic food material was improved by 4% to 20% when compared to the immune system of the control group. In fermented black garlic, the immunity enhancing effect was about 20%. Therefore, it was possible to obtain a high immunity improvement effect on the vegetable lactic acid bacteria fermented black garlic food material as a whole.
도 8의 경우는 발효시키지 않은 일반 마늘을 이용하여 면역력 측정을 한 결과를 나타내었다. 도 8에 나타낸 결과는 인체 면역력 증강 효과가 없는 것으로 나타났다. 따라서 상기 도7에서 나타낸 바와 같이 식물성유산균을 이용한 발효흑마늘에 대한 연구결과는 일반 마늘과 비교할 경우 전체적으로 약 30%~50% 정도의 인체 면역력 향상효과가 있었음을 알 수 있었다.
In the case of Figure 8 shows the results of the immunity measurement using the normal garlic not fermented. The results shown in FIG. 8 were found to have no effect on enhancing human immunity. Therefore, as shown in FIG. 7, the results of the study on fermented black garlic using vegetable lactic acid bacteria showed that the human body had about 30% to 50% improvement in immunity as compared with general garlic.
이상에서 첨부된 도면을 참조한 실시예에 의거하여 구체적으로 설명하였다. 그러나 이는 본 발명을 예시하기 위한 것으로 본 발명의 권리범위를 이에 한정하고자 하는 것은 아니고, 이들을 대체할 수 있는 다양한 균등물이 존재한다.
On the basis of the embodiments with reference to the accompanying drawings it was described in detail. However, this is not intended to limit the scope of the present invention to this intended to illustrate the present invention, there are various equivalents that can replace them.
또한 본 명세서 및 청구범위에 사용된 용어나 단어는 통상적이거나 사전적인 의미로 한정해서 해석되어서는 안 되고, 발명자는 그 자신의 발명을 가장 최선의 방법으로 설명하기 위해 용어의 개념을 적절하게 정의할 수 있다는 원칙에 입각하여 본 발명의 기술적 사상에 부합하는 의미와 개념으로 해석되어야만 한다.In addition, the terms or words used in the specification and claims should not be construed as being limited to the common or dictionary meanings, and the inventors should properly define the concept of terms in order to best explain their invention in the best way. It should be interpreted as meaning and concept corresponding to the technical idea of the present invention based on the principle that it can.
마늘의 경우 특유의 향 성분인 알리신과 매운맛을 제거하기 위한 직접적인 가열은 마늘이 갖고 있는 비타민이나 각종 미네랄 및 각종 아미노산등 의 성분을 파괴시키는 문제점이 있기 때문에 간접적으로 열을 가하는 방식인 건조열에 의하여 마늘을 숙성시키는 방법이 발달되어져 왔다.
In the case of garlic, direct heating to remove allicin and spicy taste, which are characteristic of garlic, destroys the components of vitamins, minerals, and amino acids of garlic. Methods of aging have been developed.
그러나 고온의 간접 열에 의한 숙성마늘은 숙성시간, 건조시간, 후처리시간 등의 완성 기간이 대부분 약15일 이상이 걸리는 것이 일반적이라는 문제점이 있었다.
However, the aging garlic by the high temperature indirect heat has a problem that the completion period of the ripening time, drying time, post-treatment time, etc. takes about 15 days or more in general.
이에 본 발명을 통해 식물성유산균을 이용하여 발효흑마늘을 제조하는데 소요되는 시간을 단축하고, 나아가 다양한 건강에 유리한 항산화 등의 기능성 물질을 첨가된 발효흑마늘을 제조할 수 있으므로 산업상 이용가능성이 우수하다고 할 수 있다.
Therefore, the present invention can shorten the time required to prepare fermented black garlic using vegetable lactic acid bacteria, and furthermore, it is possible to manufacture fermented black garlic added with functional substances such as antioxidants, which are beneficial to various health. Can be.
또한 본 발명의 발효흑마늘을 주원료로 하는 조미료, 첨가물 또는 식초 등에도 이용가능하므로 소비자의 다양한 욕구에 대응할 수 있다.
In addition, it can be used in seasonings, additives, vinegar, etc., the main raw material of the fermented black garlic of the present invention can respond to various needs of consumers.
나아가 경제적 측면에서 마늘 가공품 개발을 촉진함으로써 마늘의 부가가치를 더욱 높이고, 마늘 생산농가에 수익 창출은 물론 수익성 향상에 크게 기여하므로 산업상 이용가능성이 매우 우수하다고 할 것이다.In addition, it is said that the industrial availability is very excellent because it promotes the development of processed garlic products in terms of economic value, further increasing the value added of garlic and generating profits and increasing profitability for garlic producing farmers.
Claims (4)
(b) 상기 마늘의 외피 및 마늘의 내피가 제거된 마늘을 파쇄하는 단계;
(c) 상기 파쇄된 마늘의 수분이 65%~75%가 되도록 수분을 조절하는 단계;
(d) 상기 수분이 조절된 마늘을 밀봉용기에 넣어 밀봉하는 단계;
(e) 상기 밀봉된 마늘을 60℃~90℃의 건조기에서 숙성시키는 단계;
(f) 상기 숙성된 마늘에 상기 숙성된 마늘의 중량 대비 2배~10배 가수하고, 분쇄하여 흑마늘액을 제조하는 단계;
(g) 상기 흑마늘액을 80℃~90℃에서 고온살균하는 단계;
(h) 상기 살균된 흑마늘액에 효모추출물 및 칼슘(Ca), 인(P), 망간(Mg), 황(S), 소디움(Na), 칼륨(K), 염소(Cl), 철(Fe), 아연(Zn), 구리(Cu), 요오드(I), 불소(F), 셀레늄(Se), 망간(Mn), 크롬(Cr) 및 몰리브덴(Mo)으로 이루어진 군으로부터 선택된 어느 하나 이상인 미네랄을 첨가하는 단계;
(i) 상기 효모추출물 및 미네랄이 첨가된 흑마늘액에 락토바실러스 퍼멘텀(Lactobacillus fermentum JS, 특허등록번호 0435168, 특허균주기탁번호 KCCM10499)을 접종한 후, 37℃~45℃에서 발효시키는 단계;
(j) 상기 발효된 흑마늘액을 -68℃~-80℃에서 동결하여 진공건조하는 단계;
(k) 상기 건조된 발효흑마늘을 파쇄하여 분말화하는 단계;를 포함하는 것을 특징으로 하는 식물성유산균을 이용한 효모추출물 및 미네랄을 함유하는 발효흑마늘의 제조방법.
(a) removing the outer skin of garlic and the inner skin of garlic from garlic;
(b) crushing garlic in which the outer skin of garlic and the inner skin of garlic are removed;
(c) adjusting the moisture so that the water of the crushed garlic becomes 65% to 75%;
(d) sealing the moisture-controlled garlic in a sealed container;
(e) aging the sealed garlic in a dryer at 60 ℃ ~ 90 ℃;
(f) hydrolyzing 2 to 10 times the weight of the aged garlic to the aged garlic, and grinding to prepare black garlic solution;
(g) sterilizing the black garlic solution at 80 ° C to 90 ° C;
(h) Yeast extract and calcium (Ca), phosphorus (P), manganese (Mg), sulfur (S), sodium (Na), potassium (K), chlorine (Cl), iron (Fe) in the sterilized black garlic solution ), Zinc (Zn), copper (Cu), iodine (I), fluorine (F), selenium (Se), manganese (Mn), chromium (Cr) and molybdenum (Mo) Adding;
(i) inoculating the yeast extract and mineral-added black garlic solution with Lactobacillus fermentum JS (patent registration No. 0435168, patent cycle number KCCM10499), followed by fermentation at 37 ° C. to 45 ° C .;
(j) freezing the fermented black garlic solution at -68 ℃ ~ -80 ℃ vacuum drying;
(k) pulverizing the dried fermented black garlic powder; and a method for producing a fermented black garlic containing yeast extract and mineral using a vegetable lactic acid bacteria, characterized in that it comprises a.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020100045574A KR101201852B1 (en) | 2010-05-14 | 2010-05-14 | Fermented black garlic using vegetable lactic acid bacteria with yeast extract and mineral and a method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020100045574A KR101201852B1 (en) | 2010-05-14 | 2010-05-14 | Fermented black garlic using vegetable lactic acid bacteria with yeast extract and mineral and a method thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20110125930A KR20110125930A (en) | 2011-11-22 |
KR101201852B1 true KR101201852B1 (en) | 2012-11-15 |
Family
ID=45395231
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020100045574A KR101201852B1 (en) | 2010-05-14 | 2010-05-14 | Fermented black garlic using vegetable lactic acid bacteria with yeast extract and mineral and a method thereof |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR101201852B1 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101346139B1 (en) * | 2013-06-20 | 2013-12-31 | (주)새롬바이오 | Improved preparatoin method of black garlic and black onion using supersaturated salt solution and composion for improvement of lipid metabolism and liver function using them |
KR20160028735A (en) | 2014-09-04 | 2016-03-14 | 김성수 | Containing Soy Bio Aesthetics lactic acid fermented black garlic yogurt production materials |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102050652B1 (en) * | 2018-01-30 | 2019-11-29 | 장수진 | Method for preparing fermentation black garlic sikhye |
KR102140139B1 (en) * | 2018-03-22 | 2020-07-31 | 주식회사 세바바이오텍 | Skin derived novel lactic acid bacteria and cosmetic composition comprising thereof |
CN108782786B (en) * | 2018-04-25 | 2020-11-17 | 上海交通大学 | Healthy edible black garlic blend oil and preparation method thereof |
KR102149139B1 (en) * | 2018-05-29 | 2020-08-28 | 주식회사 이롬 | Fermented product of garlic and Cirsium setidens nakai by lactic acid bacteria, method of manufacturing the same, and use of the same |
KR102065585B1 (en) * | 2019-05-28 | 2020-01-13 | 재단법인 발효미생물산업진흥원 | Method for producing fermented brown rice Sikhae using Lactobacillus plantarum 3JSRL 24―4 strain |
KR20240056095A (en) | 2022-10-21 | 2024-04-30 | 허성수 | manufacturing methods of fermentation garlic |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100716133B1 (en) * | 2006-08-17 | 2007-05-08 | 주식회사 신원에프아이 | Health-improving garlic ingredient having reduced pungent flavor and method for the preparation thereof |
-
2010
- 2010-05-14 KR KR1020100045574A patent/KR101201852B1/en active IP Right Grant
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100716133B1 (en) * | 2006-08-17 | 2007-05-08 | 주식회사 신원에프아이 | Health-improving garlic ingredient having reduced pungent flavor and method for the preparation thereof |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101346139B1 (en) * | 2013-06-20 | 2013-12-31 | (주)새롬바이오 | Improved preparatoin method of black garlic and black onion using supersaturated salt solution and composion for improvement of lipid metabolism and liver function using them |
KR20160028735A (en) | 2014-09-04 | 2016-03-14 | 김성수 | Containing Soy Bio Aesthetics lactic acid fermented black garlic yogurt production materials |
Also Published As
Publication number | Publication date |
---|---|
KR20110125930A (en) | 2011-11-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101201852B1 (en) | Fermented black garlic using vegetable lactic acid bacteria with yeast extract and mineral and a method thereof | |
KR100778886B1 (en) | Preparation method of fermented fruits and vegetables, fermented fruits and vegetables prepared thereby and functional composition comprising the same | |
AU2016201194B2 (en) | Probiotic Grain-Based Compositions | |
Peñas et al. | Se improves indole glucosinolate hydrolysis products content, Se-methylselenocysteine content, antioxidant capacity and potential anti-inflammatory properties of sauerkraut | |
JP5162212B2 (en) | Novel lactic acid bacteria, lactic acid bacteria composition and plant extract, and method for producing plant extract and low molecular weight polyphenol | |
US8691220B2 (en) | Powdery malted rice extract composition | |
JP2007044014A (en) | Dried food containing lactobacillus sporogenes derived from fermented food | |
CN113677216A (en) | Microbiological method for producing bee bread | |
KR101204875B1 (en) | A functional sauce containing Fermentation Products of Cudrania tricuspidata and Manufacturing method thereo | |
Dzandu et al. | Antioxidant activity and viability of Lacticaseibacillus rhamnosus, Lacticaseibacillus casei, and Co-culture in fermented tomato juice during refrigerated storage | |
KR101923571B1 (en) | Method for Preparing Shindari Using an Extract of Korean Dendropanax | |
KR102260782B1 (en) | Fermented product of Protaetia brevitarsis extract, its preparation method and use | |
KR101276157B1 (en) | Method and culture composition for manufacturing fast-fermented bean paste capable of improving color and flavor with having antioxidative activity and anti-diabetic activity | |
KR101713176B1 (en) | Fermented medicinal-herb composition having antioxidation activity and and method for preparing thereof | |
KR20190072923A (en) | Antioxidant and Immune-enhancing functional beverage and food composition comprising the extract of edible flowers fermented by lactic acid bacteria and preparation method of the same | |
Kim et al. | Study of quality characteristics of kimchi added with Yangha (Zingiber mioga Rosc) | |
KR102070613B1 (en) | Fermented products using dendropanax morbifera and sweet potatoes, their preparation method, and functional products using the same | |
KR101263567B1 (en) | Preparation Method of Fermented Medicinal-Herb Composition And Fermented Medicinal-Herb Composition Using The Same | |
KR20070034801A (en) | Preparation of Chaga Fermented Beverage with High Hazardous Oxygen Removal Capacity | |
Singh et al. | Studies on antioxidant and antibacterial activity of nutmeg seed and its Mace | |
KR101391946B1 (en) | Food and antimicrobial agent comprising extracts of Hizikia fusiforme fermented by lactic acid bacteria | |
EP4018840A1 (en) | Food preservative composition and preparation method thereof | |
Khatib | Antioxidant and antibacterial activity of plants extracts in food industry and safety | |
KR102196276B1 (en) | Probiotic composition comprising green tea fermented extract having antibacterial activity against acne-causing resident skin flora and antioxidant efficacy | |
KR20180135565A (en) | Sweet rice drink containing tomato and eggplant lactic-acid fermented extract and its preparation method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20150824 Year of fee payment: 4 |
|
FPAY | Annual fee payment |
Payment date: 20160825 Year of fee payment: 5 |
|
FPAY | Annual fee payment |
Payment date: 20180827 Year of fee payment: 7 |